title: Rilpivirine: a step forward in tailored HIV treatment.
authors.affiliation: Molecular Medicine, KU Leuven, 3000 Leuven, Belgium.
authors.forename: Rik
authors.initials: R
authors.lastname: Schrijvers
authors.forename: Belete Ayele
authors.initials: BA
authors.lastname: Desimmie
authors.forename: Zeger
authors.initials: Z
authors.lastname: Debyser
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000480:Alkynes; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D048588:Benzoxazines / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D003521:Cyclopropanes; D020008:Delavirdine / Q000627:therapeutic use; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D015195:Drug Design; D024882:Drug Resistance, Viral / Q000235:genetics; D000068679:Emtricitabine; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D015337:Multicenter Studies as Topic; D009154:Mutation; D019829:Nevirapine / Q000627:therapeutic use; D009570:Nitriles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D063065:Organophosphonates / Q000627:therapeutic use; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000068696:Rilpivirine; D000068698:Tenofovir; D019562:Viral Load / Q000187:drug effects*
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D017320:HIV Protease Inhibitors; D009570:Nitriles; D063065:Organophosphonates; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors; D003841:Deoxycytidine; D019829:Nevirapine; D000068698:Tenofovir; D020008:Delavirdine; D000068696:Rilpivirine; D000068679:Emtricitabine; D000225:Adenine; C098320:efavirenz